Speciality healthcare solutions company.
Issues relating to incentives for life sciences research.
H.R. 523/S. 232: Protect Medical Innovation Act of 2013. Oversight of implementation of the America Invents Act.
Issues relating to patent settlements, including S. 214: Preserve Access to Affordable Generics Act.
H.R. 3309: Innovation Act.
S. 1720: Patent Transparency and Improvements Act of 2013. Issues relating to bioequivalence and related administrative procedures.
Issues relating to prescription drug abuse.
Issues relating to incentives for tamper-resistant formulations.
H.R. 486: Stop Tampering of Prescription Pills Act of 2013.Issues relating to Medicare Part D rebates.
Issues relating to health information technology.
H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013.
Compounding and drug supply chain legislation.
H.R. 3204: Drug Quality and Security Act.
Issues relating to products containing high doses of acetaminophen.
Issues relating to the labeling of generic drugs.
Issues relating to eliminating Medicare coverage for vacuum erection systems.
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE GIBSON GROUP, LLC
601 Thirteenth Street, N.W., Suite B2 North, Washington, DC, 20005, US
JOSEPH H GIBSON JOSEPH H GIBSON JOSEPH H GIBSON (Counsel, House Judiciary Comm. '95-'97)
Counsel, House Judiciary Comm. '95-'97